You can now literally ‘add to cart’ experimental peptides online—before ever speaking to a doctor. But should you be able to?
A growing number of online wellness clinics in Australia are letting customers browse and select experimental injectable peptides on their websites—sometimes even showing prices and supposed health benefits—before any doctor consultation actually happens. Guardian Australia recently investigated several such platforms and found that this new model of healthcare sits in murky legal and ethical territory.
Approved peptide-based medications like insulin and Ozempic are crucial tools in modern medicine. They’ve transformed how we treat conditions such as diabetes and obesity. But beyond these trusted drugs lies a booming digital marketplace for experimental peptides—substances promoted for everything from rapid muscle repair and fat burning to reversing signs of ageing. The catch? Many of these compounds haven’t been properly tested for safety in humans, nor approved by Australia’s Therapeutic Goods Administration (TGA). In fact, some are classified as Schedule 4 drugs, meaning they’re illegal to possess without a legitimate medical prescription.
What are peptides really?
Peptides are short chains of amino acids—the basic building blocks of proteins. Some are naturally produced in the body and have essential roles: insulin regulates blood sugar, oxytocin supports bonding and emotional connection, and endorphins reduce pain. Since the 1920s, peptide-based medicines have been crucial in medical practice. Today, more than 80 peptide drugs are officially approved worldwide, covering therapies for cancer, chronic pain, and metabolic disorders.
However, hundreds more experimental peptides are being sold online even though their scientific backing remains thin. Among the most popular are glucagon-like peptide 1 (GLP-1) receptor agonists, a class that includes semaglutide (Ozempic) and tirzepatide (Mounjaro). These mimic natural peptides responsible for appetite control. But others—such as AOD-9604, BPC-157, and thymosin β4—lack sufficient human trial data to confirm safety or effectiveness. Despite this, their use is quietly spreading across the wellness industry.
The online shopping experience for peptides
When Guardian Australia explored three prominent longevity and wellness websites, they found something surprising: all allowed users to select and add injectable peptides to their carts after simply filling out a quick health questionnaire. Products like BPC-157, MOTS-c, and NAD+ injections could be browsed freely—long before any medical consultation occurred.
Phyx, one of the investigated sites, displayed unapproved peptides promising benefits such as improved energy and recovery. After sign-up, an email encouraged customers to “explore our range of medications,” followed by an assurance that a consultation with a doctor would happen before prescribing. Still, experts question whether such systems subtly nudge users toward self-diagnosis and purchasing mindset long before an informed medical judgment takes place.
Doctors raise red flags
Dr. Jack Janetzki, a pharmacology lecturer at the University of South Australia, finds this model alarming. “It’s concerning that patients can select medicines before a consultation,” he said. “Good medical practice always starts with a professional assessment, not a shopping list.” He explained that when dealing with unapproved peptides, the burden of ensuring safety and efficacy falls heavily on doctors and compounding pharmacists.
Phyx’s spokesperson, however, defends their process. She claims the system doesn’t enable customers to buy medicines freely but rather helps doctors understand which therapies interest patients. “People often come to us after using these substances from unsafe sources,” she said. “We only prescribe when a doctor independently judges it safe and lawful.”
Regulators remain uneasy
Australia’s health regulator, Ahpra, has expressed concern that some clinics may be offering “predetermined medicines,” potentially failing to uphold the standards of good clinical practice. Their stance is clear: prescribing should only occur when there’s a genuine medical need, after thorough assessment, and always prioritizing patient welfare.
Another platform, Ageing Solutions, made available bundles of injectable NAD+ and peptides after users completed brief questionnaires on interests like anti-ageing or better sleep. While their FAQ claims that all orders are reviewed by doctors, Guardian Australia’s test profile was approved almost instantly, with no visible information on the identity of the reviewing physician. A connected company, RegenMed, offered a similar experience.
None of these peptides—such as Epitalon or NAD+ injectables—are listed in the Australian Register of Therapeutic Goods (ARTG), meaning they are not officially cleared for therapeutic use.
Legal grey areas and past penalties
Under Australian law, advertising prescription-only drugs directly to the public is banned. Yet in 2019, Peptide Clinics Australia was fined $10 million for breaching this rule by displaying restricted substances for sale online following a questionnaire. The TGA reinforced that decisions regarding such medications must always be collaborative—between the patient and a qualified clinician.
A TGA spokesperson stated that promoting online access to prescription substances, even under the guise of telehealth, likely constitutes advertising and may breach the law. Phyx maintains that it doesn’t promote prescription medicines, arguing its educational materials exist only to support “patient understanding,” not to lure buyers.
But here’s where it gets controversial... If a customer can browse drugs, see prices, and click “add to cart” before speaking to a doctor, is that truly not advertising? Or is this practice quietly reshaping how medical ethics operate in the age of e-commerce?
The debate raises deeper questions about where the line between education, convenience, and consumer manipulation should be drawn.
What do you think? Should online wellness platforms be allowed to let users preselect prescription-only drugs before a medical consult? Or does this blur the boundary between healthcare and retail too far? Share your thoughts—this conversation touches the future of how we access medicine online.
